9 June 2025 - The Australian Government is providing a further $4.5 million and listing another treatment to ensure the continuing battle against motor neurone disease is well armed.
Australians with amyotrophic lateral sclerosis, the most common type of motor neurone disease now also have access to Edaravone (Radicava) listed on the PBS.